No Data
No Data
Maxim Group Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Announces Target Price $1.5
Maxim Group Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating
Optimistic Buy Rating for Acurx Pharmaceuticals Amidst Financial Challenges and Promising Ibezapolstat Data
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target
Acurx Pharmaceuticals Analyst Ratings
Strategic Phase 3 Trials and Unique Microbiome Effects Drive Buy Rating for Acurx Pharmaceuticals
Becky007 OP : loaded. lets fly